Abstract
In blood platelets of untreated patients with endogenous depression a significantly lower concentration of serotonin (5-HT) was found than in healthy persons (P<0.05). The patients were afterwards divided into two groups: group I with mild symptoms of depression (total scores by Hamilton Depression Rating Scale below 40) and group II with severe depression (total scores above 40). The gradual diminishing of symptoms in both groups was accompanied by no change in 5-HT level in the first group and by progressive and well marked increases in platelet 5-HT content in the second one, attaining a verage normal values at the end of week 3 of treatment with maprotiline. In in vitro experiments maprotiline inhibited the uptake of 5-HT into blood platelets of healthy persons less than doxepin. After injection of maprotiline in rats (50 mg/kg IP) the turnover rate of 5-HT in the brain was only marginally affected if measured by 5-HT rise and 5-hydroxyindoleacetic acid (5-HIAA) decline after administration of the MAO inhibitor pargyline, or by estimation of 5-HIAA increase after blocking active transport with probenecid. However, after treatment with maprotiline alone, the 5-HIAA level in the rat brain was significantly increased, although the concentration of 5-HT was not altered. These results suggest: a) the possibility of an action of maprotiline on serotoninergic neurons and b) the suitability of blood platelets as a model for such an investigation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Åsberg M, Thorén P, Träskman, L, Bertilsson L, Ringberger V (1975) “Serotonin depression” — A biochemical subgroup within the affective disorders? Science 191:478–480
Banki CM (1978) 5-Hydroxytryptamine content of the whole blood in psychiatric illness and alcoholism. Acta Psychiatr Scand 57:232–238
Bein HJ (1972) The activity of two structurally analogous psychoactive compounds. In: Kielholtz P (ed) Depressive illness. Diagnosis, assessment, treatment. Hans Huber, Bern Stuttgart Vienna, pp 109–113
Benešova O, Beneš V (1974) The effect of maprotiline on brain serotonin metabolism in rats. Activ Nerv Sup (Praha) 16:190–191
Bourne HR, Bunney WE, Colburn RW, Davis JM, Davis JN, Shaw DM, Coppen AJ (1968) Noradrenaline, 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients. Lancet II 805–807
Crawford N, Rudd BT (1962) A spectrophotofluorimetric method for the determination of serotonin (5-HT) in plasma. Clin Chim Acta 7:114–121
Coppen A, Turner P, Rousell RA, Padgham C (1976) 5-Hydroxytryptamine (5-HT) in the whole blood of patients with depressive illness. Postgrad Med J 52:156–158
Coppen A, Swade C, Wood K (1978) Platelet 5-hydroxytryptamine accumulation in depressive illness. Clin Chim Acta 87:165–168
Coppen A, Swade C, Wood K (1980) Lithium restores abnormal platelet 5-HT transport in patients with affective disorders. Br J Psychiatry 136:235–238
Curzon G, Green AR (1970) Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain. Br J Pharmacol 39:653–655
Delini-Stula A (1972) The pharmacology of Ludiomil. In: Kielholtz P (ed) Depressive illness. Diagnosis, assessment, treatment. Hans Huber, Bern Stuttgart Vienna, pp 113–124
Greengrass PM, Waldmeier PC, Imholf PR, Maître L (1976) Comparison of the effects of maprotiline (Ludiomil) and clomipramine (Anafranil) on serotonin uptake and tryptophan binding in plasma. Biol Psychiatry 11:91–100
Hallstrom COS, Rees WL, Pare CMB, Trenchard A, Turner P (1976) Platelet uptake of 5-hydroxytryptamine and dopamine in depression. Postgrad Med J Suppl 3:40–45
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
Korf J (1971) Amine metabolism in the human brain: Evaluation of the probenecid test. VRB Offsetdrukkerij, Groningen
Lingjaerde O (1980) Antidepressants and the serotonin uptake in platelets. Acta Psychiatry Scand [Suppl] 280:111–119
Maître L, Waldmeier PC, Baumann PA, Staehelin M (1974) Effect of maprotiline (Ludiomil) a new antidepressant drug on serotonin uptake. In: Costa E, Gessa GL, Sandler M (eds) Serotonin: New vistas: Histochemistry and pharmacology. Raven, New York, pp 297–304
Maître L, Waldmeier PC, Greengrass JJ, Jaekel JJ, Sedlacek S, Delini-Stula A (1975) Maprotiline — its position as an antidepressant in the light of recent neuropharmacological and neurobiochemical findings. J Int Med Res Suppl 2:2–15
Neff NH, Tozer TN, Brodie BB (1967) Application of steady-state kinetics to studies of the tranfer of 5-hydroxyacetic acid from brain to plasma. J Pharmacol Exp Ther 158:214–218
Obermair W, Pöldinger W (1977) Doppelblindvergleich der Wirkungen eines neuen trizyklischen Antidepressivums (Lofepramin) und eines tetrazyklischen Antidepressivums (Marprotilin). Int Pharmacopsychiatry 12:65–71
Riess W, Rajagopalan TG, Keberle H (1972) The metabolism and pharmacokinetics of Ludiomil (maprotiline). In: Kielholz P (ed) Depressive illness. Diagnosis, assessment, treatment. Hans Huber, Bern Stuttgart Vienna, pp 140–155
Scott M, Reading HW, Loudon JB (1979) Studies on human blood platelets in affective disorder. Psychopharmacology 60:141–147
Shaw DM, Camps FE, Eccleston EC (1967) 5-Hydroxytryptamine in the hindbrain of depressive suicides. Br J Psychiatry 113:1407–1412
Sneddon JM (1973) Blood platelets as a model for monoamine-containing neurons. In: Kerkut GA, Phillis JW (eds) Progress in neurobiology, vol 1. Pergamon, Oxford, pp 151–199
Stahl SM (1977) The human platelets. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. Arch Gen Psychiatry 34:509–516
Sugrue MF (1980) Changes in rat brain monoamine turnover following chronic antidepressant administration. Life Sci 26:423–429
Tozer TN, Neff NH, Brodie BB (1966) Application of steady-state kinetics to the synthesis rate and turnover time of serotonin in the brain of normal and reserpin treated rats. J Pharmacol Exp Ther 153:177–182
Tuomisto J (1974) A new modification for studying 5-HT uptake by blood platelets: A re-evaluation of tricyclic antidepressants as uptake inhibitors. J Pharm Pharmacol 26:92–100
Tuomisto J, Tukiainen E (1976) Decreased uptake of 5-hydroxytryptamine in blood platelets from depressed patients. Nature 262:596–598
Tuomisto J, Tukiainen E, Ahlfors UG (1979) Decreased uptake of 5-hydroxytryptamine in blood platelets from patients with endogenous depression. Psychopharmacology 65:141–147
Väisänen E, Naarala M, Kontiainen, H, Meriläinen V, Heikkilä L, Malinen L (1978) Maprotiline and doxepin in the treatment of depression. A double-blind multicentre comparison. Acta Psychiatry Scand 57:193–201
Wirz-Justice A, Lichtsteiner M, Feer H (1977) Diurnal and seasonal variations in platelet serotonin in man. J Neural Transm 41:7–15
Zis AP, Goodwin FK (1979) Novel antidepressants and the biogenic amine hypothesis of depression Arch Gen Psychiatry 36:1097–1107
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mück-Šeler, D., Deanović, Ž., Jamnicky, B. et al. Maprotiline in the treatment of endogenous depression: Comparison of therapeutic effect with serotonin level in blood platelets. Psychopharmacology 79, 262–265 (1983). https://doi.org/10.1007/BF00427824
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00427824